Felipe
Prosper Cardoso
Consultor Médico
Bruno Carlos
Sangro Gómez-Acebo
Catedrático de Universidad
Publicaciones en las que colabora con Bruno Carlos Sangro Gómez-Acebo (7)
2023
-
Identification and experimental validation of druggable epigenetic targets in hepatoblastoma
Journal of Hepatology, Vol. 79, Núm. 4, pp. 989-1005
2022
-
New molecular mechanisms in cholangiocarcinoma: signals triggering interleukin-6 production in tumor cells and KRAS co-opted epigenetic mediators driving metabolic reprogramming
Journal of Experimental and Clinical Cancer Research, Vol. 41, Núm. 1
2021
-
Dual Targeting of G9a and DNA Methyltransferase-1 for the Treatment of Experimental Cholangiocarcinoma
Hepatology, Vol. 73, Núm. 6, pp. 2380-2396
-
Epigenetic mechanisms and metabolic reprogramming in fibrogenesis: Dual targeting of G9a and DNMT1 for the inhibition of liver fibrosis
Gut, Vol. 70, Núm. 2, pp. 388-400
2018
-
Deregulation of linc-PINT in acute lymphoblastic leukemia is implicated in abnormal proliferation of leukemic cells
Oncotarget, Vol. 9, Núm. 16, pp. 12842-12852
2017
-
Phase 1–2 pilot clinical trial in patients with decompensated liver cirrhosis treated with bone marrow–derived endothelial progenitor cells
Translational Research, Vol. 188, pp. 80-91.e2
1995
-
Increased concentrations of tumor necrosis factor and lnterleukin-6 contribute to the hemostatic abnormalities in advanced liver disease
Pathophysiology of Haemostasis and Thrombosis, Vol. 25, Núm. 6, pp. 305-311